Judge Trims Pfizer, Mylan EpiPen Antitrust Suit
By Kelly Lienhard · August 8, 2022, 10:45 PM EDT
A federal judge rejected most of the fourth set of antitrust claims alleging that Mylan Pharmaceuticals and Pfizer Inc. conspired to inflate the price of emergency allergy medication, saying that indirect...
To view the full article, register now.